Abstract
Neurodegeneration is one of the most important complications of diabetes mellitus (DM). The exact mechanisms underlying neurodegeneration related to diabetic complications such as cognitive deficits and peripheral neuropathy are not clarified yet. Due to the fact that CCAAT/enhancer binding proteins (C/EBPs) have roles in cognitive functions, memory, synaptic plasticity, inflammation, lipid storage, and response to neurotrophic factors, it is possible to suggest that these transcription factors could have roles in neurodegeneration. Hence, in this study, the effects of experimental diabetes on C/EBPs in the hippocampus, sciatic nerve, and ganglia tissues were examined. After experimentally induced diabetes, immunoreactivity of related proteins was measured by western blotting. C/EBPα immunoreactivity in the hippocampus was not altered at 4-weeks but significantly decreased at 12-weeks of diabetes. C/EBPβ immunoreactivity was not altered at 4-weeks whereas significantly increased at 12-weeks of diabetes. In the ganglion, C/EBPα immunoreactivity was significantly decreased in diabetes, but C/EBPβ immunoreactivity was not affected. In the sciatic nerve, C/EBPα and β immunoreactivities were significantly decreased in diabetic rats. Furthermore, insulin therapy prevented diabetes-induced alterations in C/EBPα and β immunoreactivities. This study indicated, for the first time, that DM altered the immunoreactivity of C/EBPs in the nervous system. C/EBPs might be one of the important molecular targets which are responsible for neurodegeneration seen in diabetes.
Similar content being viewed by others
References
Alam T, An MR, Papaconstantinou J (1992) Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267(8):5021–5024
Alberini CM, Ghirardi M, Metz R, Kandel ER (1994) C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76(6):1099–1114
Alberti K, Zimmet P, Consultation W (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15(7):539–553
Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF (1994) The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 37(6):579–584
Arizmendi C, Liu S, Croniger C, Poli V, Friedman JE (1999) The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 274(19):13033–13040
Bosch F, Sabater J, Valera A (1995) Insulin inhibits liver expression of the CCAAT/enhancer-binding protein beta. Diabetes 44(3):267–271
Bravenboer B, Kappelle AC, van Buren T, Erkelens DW, Gispen WH (1993) ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol 30(1):21–24
Burul-Bozkurt N, Pekiner C, Kelicen P (2010a) Diabetes alters aromatase enzyme levels in gonadal tissues of rats. Naunyn Schmiedebergs Arch Pharmacol 382(1):33–41
Burul-Bozkurt N, Pekiner C, Kelicen P (2010b) Diabetes alters aromatase enzyme levels in sciatic nerve and hippocampus tissues of rats. Cell Mol Neurobiol 30(3):445–451
Calella AM, Nerlov C, Lopez RG, Sciarretta C, von Bohlen und Halbach O, Bereshchenko O, Minichiello L (2007) Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription. Neural Dev 2:4
Cameron NE, Cotter MA, Maxfield EK (1993) Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36(4):299–304
Cao Z, Umek RM, McKnight SL (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5(9):1538–1552
Cardinaux JR, Allaman I, Magistretti PJ (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 29(1):91–97
Cermenati G, Abbiati F, Cermenati S, Brioschi E, Volonterio A, Cavaletti G, Saez E, De Fabiani E, Crestani M, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N (2012) Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res 53(2):300–310
Christy RJ, Kaestner KH, Geiman DE, Lane MD (1991) CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A 88(6):2593–2597
Cortes-Canteli M, Wagner M, Ansorge W, Perez-Castillo A (2004) Microarray analysis supports a role for CCAAT/enhancer-binding protein-beta in brain injury. J Biol Chem 279(14):14409–14417
Cotter MA, Dines KC, Cameron NE (1993) Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost. Naunyn Schmiedebergs Arch Pharmacol 347(5):534–540
Darlington GJ, Ross SE, MacDougald OA (1998) The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273(46):30057–30060
Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23(11):542–549
Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA (1997) Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem 272(41):25913–25919
Kapadia R, Tureyen K, Bowen KK, Kalluri H, Johnson PF, Vemuganti R (2006) Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J Neurochem 98(6):1718–1731
Kappelle AC, Bravenboer B, van Buren T, Traber J, Erkelens DW, Gispen WH (1993) Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat. Br J Pharmacol 108(3):780–785
King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79(8 Suppl):1527–1534
Kuhad A, Sethi R, Chopra K (2008) Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 83(3–4):128–134
Kuo CF, Xanthopoulos KG, Darnell JE Jr (1990) Fetal and adult localization of C/EBP: evidence for combinatorial action of transcription factors in cell-specific gene expression. Development 109(2):473–481
Lekstrom-Himes J, Xanthopoulos KG (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273(44):28545–28548
Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32(10):1749–1756
Lin FT, Lane MD (1992) Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev 6(4):533–544
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
Lu M, Seufert J, Habener JF (1997) Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 272(45):28349–28359
MacDougald OA, Cornelius P, Liu R, Lane MD (1995) Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes. J Biol Chem 270(2):647–654
Marshall J, Dolan BM, Garcia EP, Sathe S, Tang X, Mao Z, Blair LA (2003) Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival. Neuron 39(4):625–639
Menard C, Hein P, Paquin A, Savelson A, Yang XM, Lederfein D, Barnabe-Heider F, Mir AA, Sterneck E, Peterson AC, Johnson PF, Vinson C, Miller FD (2002) An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis. Neuron 36(4):597–610
Nadeau S, Hein P, Fernandes KJ, Peterson AC, Miller FD (2005) A transcriptional role for C/EBP beta in the neuronal response to axonal injury. Mol Cell Neurosci 29(4):525–535
Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792(10):931–940
Olofsson LE, Orho-Melander M, William-Olsson L, Sjoholm K, Sjostrom L, Groop L, Carlsson B, Carlsson LM, Olsson B (2008) CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides. J Clin Endocrinol Metab 93(12):4880–4886
Otto TC, Lane MD (2005) Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40(4):229–242
Paquin A, Barnabe-Heider F, Kageyama R, Miller FD (2005) CCAAT/enhancer-binding protein phosphorylation biases cortical precursors to generate neurons rather than astrocytes in vivo. J Neurosci 25(46):10747–10758
Perez-Capote K, Saura J, Serratosa J, Sola C (2006) Expression of C/EBPalpha and C/EBPbeta in glial cells in vitro after inducing glial activation by different stimuli. Neurosci Lett 410(1):25–30
Piotrowski P, Wierzbicka K, Smialek M (2001) Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants. Folia Neuropathol 39(3):147–154
Poli V (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273(45):29279–29282
Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365(Pt 3):561–575
Reagan LP (2007) Insulin signaling effects on memory and mood. Curr Opin Pharmacol 7(6):633–637
Reisi P, Alaei H, Babri S, Sharifi MR, Mohaddes G (2009) Effects of treadmill running on spatial learning and memory in streptozotocin-induced diabetic rats. Neurosci Lett 455(2):79–83
Roriz-Filho SJ, Sa-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves ML, Moriguti JC, Roriz-Cruz M (2009) (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 1792(5):432–443
Ross SE, Erickson RL, Hemati N, MacDougald OA (1999) Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol Cell Biol 19(12):8433–8441
Said G (2007) Diabetic neuropathy—a review. Nat Clin Pract Neurol 3(6):331–340
Soga Y, Yamanaka R, Nishino K, Tanaka R (2003) CCAAT/enhancer binding proteins are expressed in the gerbil hippocampus after transient forebrain ischemia. Neurosci Lett 337(2):106–110
Sterneck E, Johnson PF (1998) CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling. J Neurochem 70(6):2424–2433
Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP (2008) Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 11(3):309–317
Taubenfeld SM, Wiig KA, Monti B, Dolan B, Pollonini G, Alberini CM (2001) Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] Co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation. J Neurosci 21(1):84–91
ter Laak M, Lankhorst A, Schrama L, Gispen W (2000) Neuropathies. Neuroscience Research Communications 26(3):227–239
Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD (1996) Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39(11):1377–1384
Verheijen MH, Chrast R, Burrola P, Lemke G (2003) Local regulation of fat metabolism in peripheral nerves. Genes Dev 17(19):2450–2464
Webster NJ, Kong Y, Cameron KE, Resnik JL (1994) An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes 43(2):305–312
Yukawa K, Tanaka T, Tsuji S, Akira S (1998) Expressions of CCAAT/Enhancer-binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J Biol Chem 273(47):31345–31351
Zador IZ, Hsieh CC, Papaconstantinou J (1998) Renal CCAAT/enhancer-binding proteins in experimental diabetes mellitus. Nephron 79(3):312–316
Acknowledgments
This study was supported by the Hacettepe University Scientific Research Foundation (Project No: 010D03301002).
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kazkayasi, I., Burul-Bozkurt, N., Önder, S. et al. Effects of Experimental Diabetes on C/EBP Proteins in Rat Hippocampus, Sciatic Nerve and Ganglia. Cell Mol Neurobiol 33, 559–567 (2013). https://doi.org/10.1007/s10571-013-9924-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-013-9924-9